June 12, 2024
The American College of Radiology ® (ACR®) submitted comments June 6, in response to the fiscal year (FY) 2025 Hospital Inpatient Prospective Payment System (IPPS) proposed rule. The Centers for Medicare and Medicaid Services (CMS) requested stakeholder feedback on determining newness for technologies that use artificial intelligence (AI) software for New Technology Add-on Payments (NTAP).

ACR urged CMS to consider establishing a distinct, high-value AI-specific alternative NTAP pathway that would determine uniqueness based on whether the technology enables a clinically valuable task for Medicare beneficiaries not previously achievable without technology. The U.S. Food and Drug Administration currently is not required to consider a product’s value to the Medicare population as part of the Breakthrough Device designation. The College believes that value should not only be considered, but guided by input from physician experts and specialty communities for ongoing evaluations.

If you have questions, please contact Kimberly Greck, ACR Senior Economic Policy Analyst.

Related ACR News

  • Medicare Payment Increase in Final Budget Reconciliation Bill

    The bill includes a 2.5% increase to the Medicare Physician Fee Schedule for calendar year 2026.

    Read more
  • CMS Announces Prior Authorization Test Model

    WiSer is a six-year program that will begin in six states on January 1, 2026. It will introduce prior authorization using AI technology for a select number of services, including some IR procedures.

    Read more
  • Supreme Court Upholds Preventive Services Coverage

    ACR commends the Supreme Court’s ruling affirming the constitutionality of the structure and appointment process of the U.S. Preventive Services Task Force.

    Read more